Delivery Order SPE2DB22D2206-SPE2DB25FJV58
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid in 250mL quantities, with a ceiling value of $4,649.76. This firm fixed price delivery order, issued on August 28, 2025, represents a non-competitive set-aside award and is scheduled for ultimate completion by August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units with a ceiling value of $1,656.66. This firm fixed-price delivery order, which must be completed by July 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $4,713.60 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The award was made to support federal medical procurement needs, with the place of performance located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,373.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Sevoflurane inhalation liquid, with an ultimate completion date of September 3, 2025. This is a non-set-aside competitive award issued to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml units, valued at $3,299.52 with a firm fixed price structure. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,885.44 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250mL quantities. This contract was competitively awarded without set-aside provisions and operates under a firm fixed-price arrangement, with an ultimate completion date of August 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $3,989.40 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This non-set-aside, competitively awarded contract operates under firm fixed pricing and was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,414.08 on July 24, 2025, for the supply of Sevoflurane inhalation liquid in 250ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This award was made through open competition with no set-aside designation,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Sevoflurane Inhalation Liquid in 250mL units, with a ceiling value of $6,407.10 and a firm fixed price contract type. The delivery order is scheduled for completion by July 31, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sevoflurane is...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJV58Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,485.01 to AmerisourceBergen Drug Corp for the supply of Sevoflurane inhalation liquid in 250ml quantities. This contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this contract falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Sevoflurane, a volatile anesthetic commonly used in surgical and clinical settings, falls within the company's extensive portfolio of pharmaceutical commodities delivered through the DLA's global pharmaceutical support vehicle. This delivery order exemplifies the company's role in fulfilling federal medical procurement requirements on an as-needed basis through the broader prime vendor contract structure established by DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/9/25 |